Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
24,400
Total Claims
$3.8M
Drug Cost
1,090
Beneficiaries
$3,462
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 4,479 Interventional Cardiology providers
+229%
Cost per patient vs peers
$3,462 vs $1,054 avg
+46%
Brand preference vs peers
19.2% vs 13.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.4%
Opioid Rate
103
Opioid Claims
$786
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 4,622 claims · $3.1M
Generic: 19,500 claims · $673K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 726 | $441K |
| Dulaglutide | 296 | $421K |
| Sacubitril/Valsartan | 257 | $216K |
| Fluticasone/Umeclidin/Vilanter | 256 | $185K |
| Empagliflozin | 162 | $148K |
| Sitagliptin Phosphate | 175 | $142K |
| Insulin Glargine,hum.Rec.Anlog | 164 | $102K |
| Diclofenac Sodium | 165 | $70K |
| Semaglutide | 58 | $67K |
| Bictegrav/Emtricit/Tenofov Ala | 16 | $63K |
| Dapagliflozin Propanediol | 52 | $56K |
| Rivaroxaban | 82 | $56K |
| Darunavir/Cob/Emtri/Tenof Alaf | 11 | $53K |
| Budesonide/Glycopyr/Formoterol | 66 | $45K |
| Budesonide/Formoterol Fumarate | 102 | $43K |
Prescribing Profile
Patient Profile
73
Avg Age
60%
Female
2.13
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About